Title : Secondary Metabolites from the Coral-Derived Fungus Aspergillus austwickii SCSIO41227 with Pancreatic Lipase and Neuraminidase Inhibitory Activities - Chen_2023_Mar.Drugs_21_ |
Author(s) : Chen Y , He Y , Pang X , Zhou X , Liu Y , Yang B |
Ref : Mar Drugs , 21 : , 2023 |
Abstract :
The coral-derived fungus Aspergillus austwickii SCSIO41227 from Beibu Gulf yielded four previously uncharacterized compounds, namely asperpentenones B-E (1-4), along with twelve known compounds (5-16). Their structures were elucidated using HRESIMS and NMR ((1)H and (13)C NMR, HSQC, HMBC), among which the stereo-structure of compounds 1-3 was determined by calculated ECD. Furthermore, compounds 1-16 were evaluated in terms of their enzyme (acetylcholinesterase (AChE), pancreatic lipase (PL), and neuraminidase (NA)) inhibitory activities. These bioassay results revealed that compounds 2 and 14 exerted noticeable NA inhibitory effects, with IC(50) values of 31.28 and 73.64 microM, respectively. In addition, compound 3 exhibited a weak inhibitory effect against PL. Furthermore, these compounds showed the potential of inhibiting enzymes in silico docking analysis to demonstrate the interactions between compounds and proteins. |
PubMedSearch : Chen_2023_Mar.Drugs_21_ |
PubMedID: 37999391 |
Chen Y, He Y, Pang X, Zhou X, Liu Y, Yang B (2023)
Secondary Metabolites from the Coral-Derived Fungus Aspergillus austwickii SCSIO41227 with Pancreatic Lipase and Neuraminidase Inhibitory Activities
Mar Drugs
21 :
Chen Y, He Y, Pang X, Zhou X, Liu Y, Yang B (2023)
Mar Drugs
21 :